Änderungen

Die US-amerikanische FDA entschied 1999, dass kolloidales Silber in den USA nicht als sicheres OTC-Produkt angesehen werden kann (Zitat: ''"[...] are not generally recognized as safe and effective and are misbranded."''<ref>http://homepages.together.net/~rjstan/finalrule.html</ref><ref>http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Over-the-CounterOTCDrugs/StatusofOTCRulemakings/ucm071111.htm</ref><ref>http://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm127976.htm</ref>) Die FDA berichtet auf einer ihrer Seiten<ref>http://www.fda.gov/oc/nutritioninitiative/report.html</ref> von einer Verurteilung zu vier Monaten wegen des ungesetzlichen Verkaufs von kolloidalem Silber: ''U.S. v. Diane Eckert-Kunick, No. MG-F-02-2093 (E.D. Cal.). In 1996, Diane Eckert-Kunick, along with her parents, formed New Gaia Products ("NGP"). The company manufactured, distributed, and sold dietary supplements including colloidal gold, colloidal silver, and colloidal titanium. Eckert-Kunick also distributed promotional literature claiming that NGP products cured cancer, rheumatoid arthritis and heart disease. In April 2002, Eckert-Kunick was convicted of introducing unapproved new drugs into interstate commerce. She received a sentence of four months incarceration in a community correctional center.'' und fügt hinzu: ''Colloidal Silver Products: These products are promoted as alternatives to antibiotics intended for serious infectious diseases. They also are promoted to protect against anthrax. Colloidal silver is completely ineffective. It is marketed for use by children and can cause severe adverse consequences, including argyria (blue-gray discoloration of the skin caused by the ingestion of silver). This condition is irreversible.''

Die US-amerikanische FDA entschied 1999, dass kolloidales Silber in den USA nicht als sicheres OTC-Produkt angesehen werden kann (Zitat: ''"[...] are not generally recognized as safe and effective and are misbranded."''<ref>http://homepages.together.net/~rjstan/finalrule.html</ref><ref>http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Over-the-CounterOTCDrugs/StatusofOTCRulemakings/ucm071111.htm</ref><ref>http://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm127976.htm</ref>) Die FDA berichtet auf einer ihrer Seiten<ref>http://www.fda.gov/oc/nutritioninitiative/report.html</ref> von einer Verurteilung zu vier Monaten wegen des ungesetzlichen Verkaufs von kolloidalem Silber: ''U.S. v. Diane Eckert-Kunick, No. MG-F-02-2093 (E.D. Cal.). In 1996, Diane Eckert-Kunick, along with her parents, formed New Gaia Products ("NGP"). The company manufactured, distributed, and sold dietary supplements including colloidal gold, colloidal silver, and colloidal titanium. Eckert-Kunick also distributed promotional literature claiming that NGP products cured cancer, rheumatoid arthritis and heart disease. In April 2002, Eckert-Kunick was convicted of introducing unapproved new drugs into interstate commerce. She received a sentence of four months incarceration in a community correctional center.'' und fügt hinzu: ''Colloidal Silver Products: These products are promoted as alternatives to antibiotics intended for serious infectious diseases. They also are promoted to protect against anthrax. Colloidal silver is completely ineffective. It is marketed for use by children and can cause severe adverse consequences, including argyria (blue-gray discoloration of the skin caused by the ingestion of silver). This condition is irreversible.''

==Nebenwirkungen: Argyrie und Argyrose==

==Nebenwirkungen: Argyrie und Argyrose==